Pulmonx (LUNG) Net Margin Growth (1y) (2020 - 2025)
Pulmonx (LUNG) Net Margin Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | -430.00 |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | 656.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 201.00 |
| 10 | Pulmonx | 50.97 Mn | -18.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 460.00 |
| Jun 30, 2025 | 1,023.00 |
| Mar 31, 2025 | 889.00 |
| Dec 31, 2024 | 1,660.00 |
| Sep 30, 2024 | 1,496.00 |
| Jun 30, 2024 | 2,014.00 |
| Mar 31, 2024 | 3,612.00 |
| Dec 31, 2023 | 2,060.00 |
| Sep 30, 2023 | 2,063.00 |
| Jun 30, 2023 | 1,099.00 |
| Mar 31, 2023 | 3,795.00 |
| Dec 31, 2022 | 224.00 |
| Sep 30, 2022 | -2,852.00 |
| Jun 30, 2022 | 144.00 |
| Mar 31, 2022 | -1,171.00 |
| Dec 31, 2021 | -30.00 |
| Sep 30, 2021 | -4,007.00 |
| Jun 30, 2021 | 21,910.00 |
| Mar 31, 2021 | -5,224.00 |
| Dec 31, 2020 | -4,945.00 |